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Abstract HL-60 cells are human promyelocytic cells expressing
two ATP receptors : the P2Y2 and P2Y11 subtypes. Our
Northern blotting experiments have shown that P2Y2 and
P2Y11 messengers were up-regulated in these cells, rapidly and
independently of protein synthesis, following treatment with
granulocytic differentiating agents such as retinoic acid,
dimethylsulfoxide, granulocyte-colony stimulating factor, dibu-
tyryl cyclic AMP and ATP. AR-C67085 and adenosine 5P-O-(3-
thiotriphosphate), two potent agonists of the recombinant P2Y11
receptor, increased intracellular cAMP concentration in HL-60
cells more potently than ATP itself. These observations support
the conclusion that the effect of ATP on HL-60 cell differentia-
tion is mediated by the P2Y11 receptor. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
HL-60 cells are an established human promyelocytic leuke-
mia cell line. They are induced to di¡erentiate into neutrophil-
like cells by various agents including retinoic acid (RA) [1],
dimethylsulfoxide (Me2SO) [2], granulocyte-colony stimulat-
ing factor (G-CSF) [3] and cell-permeable forms of cyclic
AMP (cAMP) such as N6,2P-O-dibutyryl cAMP (dbcAMP)
[4]. More recently, extracellular ATP has been reported to
induce growth inhibition and di¡erentiation of HL-60 cells
into granulocytes through an increase in the intracellular
cAMP concentration [5^7]. Phorbol 12-myristate 13-acetate
(TPA) and 1K,25-dihydroxycholecalciferol (1,25-(OH)2D3)
are known to di¡erentiate these cells into monocyte-like cells
[8,9].
Nucleotide receptors have been classi¢ed into the intrinsic
cation channel P2X family and the G-protein-linked receptor
P2Y family. Two subtypes of P2Y receptors have been de-
scribed on HL-60 cells. The activation of P2Y2 receptors by
ATP or UTP increases the cytosolic calcium concentration
[10,11] and in cells di¡erentiated by dbcAMP enhances the
superoxide anion production [12]. ATP is also able to induce
an intracellular cAMP increase and the granulocytic di¡eren-
tiation of HL-60 cells through the activation of another P2Y
subtype [5,7,13]. The recently cloned P2Y11 receptor is dually
coupled to phospholipase C and adenylyl cyclase stimulation
[14]. P2Y11 mRNA has been detected by Northern blotting in
HL-60 cells [14] and the pharmacological pro¢le of the re-
combinant P2Y11 receptor closely matched that of the ATP
stimulation of cAMP formation in HL-60 cells [15]. These
data suggest the involvement of the P2Y11 receptor in the
granulocytic di¡erentiation of HL-60 cells by ATP. In the
present paper, we have studied the regulation of P2Y2 and
P2Y11 messengers in HL-60 cells during granulocytic di¡er-
entiation. Furthermore, we have investigated the e¡ect on
HL-60 cells of potent agonists of the recombinant P2Y11 re-
ceptor.
2. Materials and methods
2.1. Materials
HL-60 cells were obtained from the American Type Culture Col-
lection (Rockville, MD, USA). RPMI 1640 medium, fetal bovine
serum (FBS) and antibiotics were purchased from Gibco BRL (Grand
Island, NY, USA). ATP, ATPQS (adenosine 5P-O-(3-thiotriphos-
phate)), cycloheximide, all-trans-RA, 1,25-(OH)2D3, dbcAMP,
Me2SO, TPA and G-CSF were obtained from Sigma (St. Louis,
MO, USA). Rolipram was a gift from the Laboratoires Jacques Lo-
geais (Trappes, France). AR-C67085 (2-propylthio-L,Q-dichloromethy-
lene-D-ATP) was a generous gift of Dr. J.D. Turner and Dr. P. Le¡
(Astra Charnwood).
2.2. Cell culture
HL-60 cells were cultured at 37‡C with 5% CO2 in the following
complete medium: 10% FBS, 100 U/ml penicillin, 100 Wg/ml strepto-
mycin, 2.5 Wg/ml amphotericin B and 5 mM L-glutamine in RPMI
1640 medium. The HL-60 cells were di¡erentiated by the addition of
various agents during di¡erent times in the culture medium: 160 nM
Me2SO, 1 WM RA, 200 WM dbcAMP, 10 ng/ml G-CSF, 100 WM
ATPQS, 100 nM TPA or 10 nM 1,25-(OH)2D3.
2.3. Northern blot analysis
HL-60 cells (106 cells/ml) were incubated for various times in the
presence of the di¡erentiating agents. They were then centrifuged and
the pellets were stored at 380‡C. The total RNA extraction was made
using the RNeasy kit (Qiagen). Fifteen Wg of total RNA was loaded in
each lane. The P2Y2 and P2Y11 probes corresponded to a large frag-
ment of the open reading frame of these two genes (TM1 to TM7).
The blots were prehybridized for 8 h at 42‡C in 50% formamide, 0.3%
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SDS solution and hybridized in the same solution supplemented with
10% dextran sulfate and the K-32P-labeled probe. The ¢nal washing
conditions were 0.2 SSC and 0.1% SDS at 65‡C. The blots were
exposed during 6 days and visualized using the PhosphorImager SI
(Molecular Dynamics). The presence of equal amounts of RNA on
each lane was checked using acridine-orange coloration.
2.4. cAMP measurements
HL-60 cells were cultured in RPMI 1640 complete medium. Cells
were centrifuged, resuspended at a density of 3U106 cells/ml for
30 min in Krebs^Ringer HEPES bu¡er of the following composition
(124 mM NaCl, 5 mM KCl, 1.25 mM MgSO4, 1.45 mM CaCl2,
1.25 mM KH2PO4, 25 mM HEPES (pH 7.4) and 8 mM glucose)
containing 25 WM rolipram and incubated in the same medium for
15 min in the presence of the agonists. The incubation was stopped by
the addition of 1 ml 0.1 M HCl. The medium was dried up, resus-
pended in water and diluted as required. cAMP was quanti¢ed by
radioimmunoassay after acetylation as previously described [16].
EC50 values were obtained by curve ¢tting (Sigma Plot: version 2.0).
2.5. FACS analysis
HL-60 cells were incubated with the tested agents for 4 days, the
medium and agents being renewed after 2 days. The cells were then
centrifuged, concentrated (5U106 cells/ml) in phosphate-bu¡ered sa-
line^0.1% bovine serum albumin, containing naive mouse serum (1/25)
for 30 min at room temperature, washed and resuspended at the same
concentration. One hundred Wl of the suspension was incubated for
30 min at room temperature, in the dark, with the phycoerythrin-
conjugated IGg2A speci¢c monoclonal antibody (1/100) directed
against the surface CD11b protein (Becton Dickinson). After washing,
the £uorescence of 5000 cells/tube was assayed by a FACScan £ow
cyto£uorometer (Becton Dickinson). Data were analyzed using the
CELLQuest v3.1 software (Becton Dickinson).
3. Results
We have tested the e¡ect of several di¡erentiating agents on
the level of P2Y2 and P2Y11 messengers by Northern blotting
experiments (Fig. 1). Several messengers were detected for
each receptor. For the P2Y11 receptor, an e¡ect on the level
of messengers was observed at an early stage (after 1 h) for all
the tested agents: RA (1 WM), Me2SO (1.25%), dbcAMP (200
WM), G-CSF (10 ng/ml) and ATPQS (100 WM) (Fig. 1A^C). A
decrease in messenger levels was observed after this ¢rst peak
(1^2 h) and a second weakly detectable increase was in general
observed around 20 h. All the di¡erent P2Y11 variants seemed
to be up-regulated by the di¡erentiating agents with a similar
time course. However it was clear that Me2SO, dbcAMP and
ATPQS up-regulated mostly short P2Y11 messengers (2 kb),
whereas up-regulations of longer P2Y11 messengers (2.5, 3.6,
4.3 and 6 kb) were more clearly observed with RA and G-
CSF. The up-regulation observed with ATPQS was lower than
with the other agents but signi¢cant. For the P2Y2 receptor,
up-regulations of four variants were observed after 1 h, except
for Me2SO and ATPQS which were unable to increase the level
of P2Y2 messengers (data not shown). The presence of equiv-
alent amounts of RNA in each lane was checked using acri-
dine-orange coloration (data not shown).
The response to the di¡erentiating agents under our exper-
imental conditions was checked by the measurement of O32
generation from HL-60 cells stimulated by fMLP and nucleo-
tides, using the ferricytochrome c reduction assays. There was
clearly no O32 generation in the non-di¡erentiated HL-60
cells. On the contrary, Me2SO- or RA-treated HL-60 cells
showed a basal level of O32 generation and stimulation by
fMLP, which was enhanced by ATP and UTP (data not
shown). The amount of CD11b on the cell surface was also
assessed (Fig. 2). An increase in CD11b protein expression
was observed for all tested agents (Fig. 2A^D). Relative to
RA and G-CSF alone, their combination with ATPQS en-
hanced the expression of CD11b (Fig. 2C,D), similar to that
previously reported for the RA and G-CSF combination [17].
AR-C67085, which is a potent agonist of the P2Y11 receptor
[15], induces a signi¢cant increase (Fig. 2E) whereas UTP,
which activates P2Y2 receptors, did not (data not shown).
The up-regulation of P2Y2 and P2Y11 messengers at an
early stage by RA was maintained, with the same time course,
after cell treatment by cycloheximide (50 Wg/ml) (data not
shown).
TPA and 1,25-(OH)2D3, known inducers of the monocytic
di¡erentiation of HL-60 cells, were also tested in this study.
TPA and 1,25-(OH)2D3 did not up-regulate P2Y11 mRNA
(data not shown). A detectable down-regulation of P2Y2 tran-
scripts was observed with TPA (data not shown).
Fig. 1. Modulation of P2Y11 messengers during granulocytic di¡er-
entiation in HL-60 cells. Northern blotting experiments have been
performed with total RNA (15 Wg per lane) extracted from HL-60
cells exposed for di¡erent times to Me2SO (160 nM), RA (1 WM),
dbcAMP (200 WM), G-CSF (10 ng/ml) and ATPQS (100 WM). The
RNA from the di¡erent cell lines were prepared with the RNeasy
kit (Qiagen). The P2Y11 probe corresponds to a large fragment of
the open reading frame of the P2Y11 gene (TM1 to TM7). The mes-
sengers are indicated by black arrowheads (2, 2.5, 3.6, 4.3 and 6 kb).
The blots were treated as described in Section 2. The blots were ex-
posed during 6 days and visualized using the PhosphorImager SI
(Molecular Dynamics). These Northern blotting experiments have
been reproduced twice.
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The ATP derivative AR-C67085, which is inactive at P2Y1
receptors and is an antagonist of the P2TAC receptor [18], was
recently shown to be a potent agonist of the recombinant
P2Y11 receptor [15]. AR-C67085 increased cAMP in HL-60
cells more potently than ATP itself and with a similar potency
as ATPQS (EC50 AR-C67085 = 32.2 þ 6.4 WM; EC50
ATPQS = 32.4 þ 5.8 WM; EC50 ATP = 282 þ 31 WM; mean þ
S.D. of three independent experiments) (Fig. 3). The maximal
e¡ect of AR-C67085 was lower than that of ATP and ATPQS,
as described for the recombinant P2Y11 receptor [15].
4. Discussion
HL-60 cells are promyelocytic cells which are able to di¡er-
entiate into granulocytes or monocytic cells depending on the
stimuli. Pharmacological data obtained in HL-60 cells are
compatible with the expression of P2Y2 and P2Y11 receptors
[5,10]. Furthermore, Northern blotting has demonstrated the
presence of P2Y2 [19] and P2Y11 [14] transcripts in the non-
di¡erentiated HL-60 cells. It was also previously reported that
dbcAMP induces a rapid up-regulation of P2Y2 mRNA in
HL-60 cells [19] and that the P2Y11 2 kb length mRNA level
is increased following a 6 day exposure to RA or Me2SO [14].
From these latest results it was unclear if P2Y11 mRNA up-
regulation was a consequence of granulocytic di¡erentiation
or might constitute an early event preceding that di¡erentia-
tion. In the present study, we have shown that the level of
P2Y2 and P2Y11 messengers was strongly increased when the
cells were stimulated to di¡erentiate into neutrophil-like cells
by RA, dbcAMP and G-CSF. Me2SO and ATPQS were only
able to up-regulate P2Y11 messengers. TPA and 1,25-(OH)2D3
did not up-regulate P2Y11 mRNA and, as described previ-
ously, TPA down-regulated P2Y2 mRNA [19].
The up-regulation of P2Y messengers was observed at an
early time of stimulation by the di¡erentiating agent (1 h) and
was maintained during several hours. In some cases, a second
weaker increase around 20 h of di¡erentiation was observed.
The up-regulation at an early stage by RA was not inhibited
by a treatment of the cells with cycloheximide, suggesting that
P2Y2 and P2Y11 receptors behave as immediate early genes of
RA in the granulocytic di¡erentiating process of the HL-60
cells. This is reminiscent of previous reports showing that the
P2Y2 receptor behaves as an early gene in response to gluco-
corticoids in activated mouse thymocytes [20]. Up-regulation
of P2Y2 mRNA by retinoids has also been observed in human
uterine cervical cells [21].
Several messengers were detected for each receptor in our
Northern blotting experiments. This has been reported previ-
ously for the P2Y2 receptor [21,22]. The presence of at least
one intron in the P2Y11 open reading frame has also been
previously reported [14]. Alternative splicing and the potential
existence of alternative polyadenylation sites in the non-cod-
ing regions of P2Y2 and P2Y11 messengers could explain the
existence of at least four variants for each subtype. Each
variant seemed to follow a similar time course of regulation
but some variants were more up-regulated than others de-
pending on the agent tested. This was particularly clear on
the Northern blotting data showing the regulation of P2Y11
messengers by Me2SO and RA. Me2SO up-regulated strongly
a short variant of the P2Y11 messenger whereas RA up-regu-
lated longer variants. At this stage the physiological relevance
of these variants and their respective involvement in the gran-
Fig. 2. FACS analysis of CD11b expression in HL-60 cells during
granulocytic di¡erentiation. HL-60 cells were exposed to Me2SO
(160 nM), RA (1 WM), dbcAMP (200 WM), G-CSF (10 nM), ATPQS
(100 WM), AR-C67085 (100 WM) or a combination of two agents
(RA 1 WM+ATPQS 100 WM and G-CSF 10 nM+ATPQS 100 WM)
during 4 days. The cells were treated as described in Section 2.
Data were obtained and analyzed using the FACScan £ow cyto-
£uorometer and the CELLQuest v3.1 software (Becton Dickinson).
These data were reproduced in three independent experiments.
Fig. 3. E¡ect of AR-C67085, ATPQS and ATP on cAMP accumula-
tion in HL-60 cells. HL-60 cells were incubated during 15 min with
various concentrations of ATP, ATPQS and AR-C67085. The data
are the mean þ S.D. of triplicate points obtained in one experiment
representative of three.
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ulocytic di¡erentiation process of the HL-60 cells remain un-
clear.
The pharmacological pro¢le of the recombinant P2Y11 re-
ceptor [15] is similar to that of the cAMP and di¡erentiation
responses of HL-60 cells to ATP [7]. In particular, the rank
order of potency of various ATP analogs was identical :
ATPQSWBzATPWdATPsATP. The fact that the absolute
EC50 values do not match up could be due to the high ex-
pression of recombinant P2Y11 receptors in CHO-K1 trans-
fected cells. The study of the recombinant P2Y11 receptor
revealed that the ATP derivative AR-C67085 was 12-fold
more potent than ATP in stimulating cAMP accumulation.
Our observation that it is also more potent than ATP in in-
creasing cAMP in HL-60 cells whereas UTP has no cAMP or
di¡erentiation e¡ect strengthens the conclusion that these ef-
fects of ATP are mediated by the P2Y11 receptor.
In this study we have thus demonstrated that agents induc-
ing the granulocytic di¡erentiation of HL-60 cells via diverse
signalling pathways share the ability to rapidly up-regulate the
P2Y11 receptor, which is the ATP receptor involved in this
di¡erentiation. This suggests that ATP might have a physio-
logical role in the di¡erentiation induced by other mediators.
In a similar way, RA has been shown to up-regulate the G-
CSF receptor [17,23] and Stat1/2 [24] mRNA in HL-60 cells,
but only the last e¡ect constitutes an immediate early gene
response. Targeting of the murine P2Y11 gene is under way to
determine the physiological importance of this receptor in the
maturation of neutrophils.
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